These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 7504454)

  • 41. CD44 and the adhesion of neoplastic cells.
    Rudzki Z; Jothy S
    Mol Pathol; 1997 Apr; 50(2):57-71. PubMed ID: 9231152
    [TBL] [Abstract][Full Text] [Related]  

  • 42. CD44 variant exon epitopes in primary breast cancer and length of survival.
    Kaufmann M; Heider KH; Sinn HP; von Minckwitz G; Ponta H; Herrlich P
    Lancet; 1995 Mar; 345(8950):615-9. PubMed ID: 7534855
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Alternatively spliced CD44 transcripts in diffuse large-cell lymphomas: characterization and comparison with normal activated B cells and epithelial malignancies.
    Salles G; Zain M; Jiang WM; Boussiotis VA; Shipp MA
    Blood; 1993 Dec; 82(12):3539-47. PubMed ID: 7505117
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Predominant expression of CD44 splice variant v10 in malignant and reactive human skin lymphocytes.
    Wagner SN; Wagner C; Reinhold U; Funk R; Zöller M; Goos M
    J Invest Dermatol; 1998 Sep; 111(3):464-71. PubMed ID: 9740242
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Expression of CD44 variant form in human renal cell carcinoma].
    Kanayama H; Kan M; Aki M; Kagawa S
    Nihon Rinsho; 1995 Jul; 53(7):1710-5. PubMed ID: 7630012
    [TBL] [Abstract][Full Text] [Related]  

  • 46. CD44 variant expression in cutaneous T-cell lymphoma.
    Orteu CH; Li W; Allen MH; Smith NP; Barker JN; Whittaker SJ
    J Cutan Pathol; 1997 Jul; 24(6):342-9. PubMed ID: 9243361
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Expression of alternatively spliced forms of the CD44 extracellular-matrix receptor on human lung carcinomas.
    Jackson DG; Schenker T; Waibel R; Bell JI; Stahel RA
    Int J Cancer Suppl; 1994; 8():110-5. PubMed ID: 7515025
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Expression of mutant p53 protein and CD44 variant proteins in colorectal tumorigenesis.
    Mulder JW; Wielenga VJ; Polak MM; van den Berg FM; Adolf GR; Herrlich P; Pals ST; Offerhaus GJ
    Gut; 1995 Jan; 36(1):76-80. PubMed ID: 7534253
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Participation in normal immune responses of a metastasis-inducing splice variant of CD44.
    Arch R; Wirth K; Hofmann M; Ponta H; Matzku S; Herrlich P; Zöller M
    Science; 1992 Jul; 257(5070):682-5. PubMed ID: 1496383
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Occurrence of CD44 and its isoforms under orthological and pathological conditions].
    Terpe A; Franke F; Stark H; Gustmann C; Mackay C; Marston W; Günthert U
    Verh Dtsch Ges Pathol; 1993; 77():276-81. PubMed ID: 7511297
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Regulated expression of exon v6 containing isoforms of CD44 in man: downregulation during malignant transformation of tumors of squamocellular origin.
    Salmi M; Grön-Virta K; Sointu P; Grenman R; Kalimo H; Jalkanen S
    J Cell Biol; 1993 Jul; 122(2):431-42. PubMed ID: 8320265
    [TBL] [Abstract][Full Text] [Related]  

  • 52. CD44 variant isoforms in non-Hodgkin's lymphoma: a new independent prognostic factor.
    Stauder R; Eisterer W; Thaler J; Günthert U
    Blood; 1995 May; 85(10):2885-99. PubMed ID: 7537983
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Expression of CD44 variant exons 8-10 in colorectal cancer and its relationship to metastasis.
    Takeuchi K; Yamaguchi A; Urano T; Goi T; Nakagawara G; Shiku H
    Jpn J Cancer Res; 1995 Mar; 86(3):292-7. PubMed ID: 7538103
    [TBL] [Abstract][Full Text] [Related]  

  • 54. CD44 in colon cancer.
    Herrlich P; Pals S; Ponta H
    Eur J Cancer; 1995; 31A(7-8):1110-2. PubMed ID: 7577002
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Novel variants of CD44 arising from alternative splicing: changes in the CD44 alternative splicing pattern of MCF-7 breast carcinoma cells treated with hyaluronidase.
    Tanabe KK; Nishi T; Saya H
    Mol Carcinog; 1993; 7(4):212-20. PubMed ID: 8352881
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A directly spliced exon 10-containing CD44 variant promotes the metastasis and homotypic aggregation of aggressive non-Hodgkin's lymphoma.
    Yakushijin Y; Steckel J; Kharbanda S; Hasserjian R; Neuberg D; Jiang W; Anderson I; Shipp MA
    Blood; 1998 Jun; 91(11):4282-91. PubMed ID: 9596677
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Activated mouse astrocytes and T cells express similar CD44 variants. Role of CD44 in astrocyte/T cell binding.
    Haegel H; Tölg C; Hofmann M; Ceredig R
    J Cell Biol; 1993 Sep; 122(5):1067-77. PubMed ID: 8354694
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Colorectal cancer prognosis and expression of exon-v6-containing CD44 proteins.
    Parker D
    Lancet; 1995 Mar; 345(8949):583-4. PubMed ID: 7539877
    [No Abstract]   [Full Text] [Related]  

  • 59. Patterns of splice variant CD44 expression by normal human urothelium in situ and in vitro and by bladder-carcinoma cell lines.
    Southgate J; Trejdosiewicz LK; Smith B; Selby PJ
    Int J Cancer; 1995 Aug; 62(4):449-56. PubMed ID: 7543458
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Characteristics of CD44 alternative splice pattern in the course of human colorectal adenocarcinoma progression.
    Bánky B; Rásó-Barnett L; Barbai T; Tímár J; Becságh P; Rásó E
    Mol Cancer; 2012 Nov; 11():83. PubMed ID: 23151220
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.